bf/AMEX:IBIO_icon.jpeg

COM:IBIOINC

iBio

  • Stock

Last Close

2.45

22/11 21:00

Market Cap

17.07M

Beta: -

Volume Today

307.26K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
646.50K
-
137.50K
78.73%
93.50K
32%
24K
74.33%
13K
45.83%
399K
-
412.50K
3.38%
1.96M
376%
12.49M
536.36%
10.54M
15.61%
average payables
1.35M
-
700.50K
48.07%
1.14M
62.81%
963K
15.56%
769.50K
20.09%
895.50K
16.37%
1.38M
54.10%
2.01M
45.40%
3.26M
62.42%
3.06M
6.21%
1.10M
63.90%
average receivables
606K
-
325K
46.37%
525.50K
61.69%
390.50K
25.69%
125K
67.99%
86K
31.20%
2.86M
3,226.16%
5.58M
94.90%
5.81M
4.27%
3.15M
45.78%
458.50K
85.45%
book value per share
24.21
-
39.27
62.18%
30.68
21.88%
25.01
18.49%
38.02
52.01%
3.25
91.44%
22.54
592.83%
346.92
1,439.06%
181.99
47.54%
1.26
99.31%
5.57
343.13%
capex per share
-1.03
-
-0.75
26.89%
-0.21
72.07%
-4.47
2,028.73%
-2.54
43.22%
-1.31
48.46%
-0.46
64.87%
-16.49
3,489.66%
-33.34
102.15%
-0.47
98.59%
0.05
111.70%
capex to depreciation
-0.72
-
-0.59
17.45%
-0.07
87.79%
-0.95
1,213.90%
-0.63
33.57%
-0.57
10.35%
-0.51
9.03%
-2.14
315.26%
-3.07
43.46%
-4.16
35.54%
0.72
117.36%
capex to operating cash flow
0.06
-
0.05
27.69%
0.01
81.49%
0.12
1,336.59%
0.08
33.86%
0.07
11.50%
0.09
22.07%
0.17
98.56%
0.31
80.72%
0.19
39.24%
-0.01
106.00%
capex to revenue
-1.26
-
-0.12
90.81%
-0.07
38.25%
-4.04
5,536.62%
-2.43
39.89%
-0.49
79.81%
-0.70
43.61%
-2.18
209.03%
-4.88
124.17%
0.93
-
cash per share
14.25
-
33.20
132.92%
71.05
114.03%
22.69
68.07%
37.47
65.13%
5.84
84.41%
21.94
275.72%
309.82
1,312.05%
96.09
68.98%
0.35
99.63%
3.71
956.02%
days of inventory on hand
6.74
-
6.59K
97,667.49%
days payables outstanding
562.73
-
7.21K
1,180.43%
days sales outstanding
365.00
-
87.75
75.96%
233.32
165.90%
162.12
30.52%
61.66
61.97%
17.54
71.54%
1.25K
7,043.00%
850.69
32.12%
934.33
9.83%
1.16K
-
debt to assets
0.49
-
0.70
42.34%
0.58
17.03%
0.81
39.75%
0.35
57.06%
0.22
36.27%
0.28
25.58%
0.41
48.20%
0.12
70.80%
debt to equity
2.56
-
2.83
10.73%
1.55
45.26%
10.10
551.20%
0.58
94.25%
0.30
48.15%
0.44
45.28%
1.11
153.56%
0.16
85.32%
dividend yield
0.15
-
0.00
-
earnings yield
-0.14
-
-0.10
29.53%
-0.17
71.70%
-0.42
152.26%
-1.68
298.41%
-1.34
20.57%
-0.14
89.85%
-1.97
1,350.78%
-22.15
1,025.42%
-0.20
99.11%
-3.23
1,548.55%
enterprise value
22.89M
-
58.43M
155.20%
60.72M
3.93%
51.57M
15.07%
18.71M
63.71%
33.62M
79.65%
117.20M
248.58%
-32.87M
128.04%
7.42M
122.57%
162.16M
2,085.67%
-3.03M
101.87%
enterprise value over ebitda
-6.93
-
-9.27
33.77%
-6.81
26.48%
-4.11
39.62%
-1.50
63.57%
-2.41
60.80%
-9.99
314.25%
1.06
110.63%
-0.16
115.29%
-5.53
3,308.36%
0.20
103.55%
ev to operating cash flow
-5.56
-
-12.37
122.31%
-7.52
39.16%
-3.92
47.92%
-1.39
64.57%
-2.41
73.29%
-8.78
265.04%
1.09
112.45%
-0.20
118.11%
-5.33
2,591.51%
0.16
103.07%
ev to sales
111.68
-
31.56
71.74%
64.05
102.92%
130.90
104.36%
42.15
67.80%
16.66
60.47%
71.55
329.45%
-13.86
119.37%
3.11
122.46%
-13.48
-
free cash flow per share
-17.37
-
-17.27
0.55%
-25.13
45.49%
-41.40
64.72%
-34.24
17.30%
-19.77
42.26%
-5.77
70.80%
-112.54
1,849.69%
-140.78
25.09%
-2.95
97.90%
-4.90
65.80%
free cash flow yield
-0.17
-
-0.07
55.97%
-0.14
91.97%
-0.43
207.26%
-1.52
254.70%
-1.14
25.26%
-0.10
90.85%
-2.98
2,766.43%
-21.33
615.48%
-0.24
98.86%
-2.44
906.33%
graham net net
13.51
-
30.24
123.75%
-12.59
141.62%
-52.92
320.47%
-25.70
51.44%
-31.22
21.48%
8.82
128.24%
200.42
2,173.08%
11.82
94.10%
-0.88
107.48%
1.91
316.53%
graham number
89.05
-
143.07
60.66%
144.26
0.83%
151.46
5.00%
179.99
18.83%
41.25
77.08%
61.80
49.83%
761.60
1,132.37%
773.76
1.60%
8.23
98.94%
28.53
246.92%
income quality
1.12
-
0.71
36.48%
0.76
6.20%
0.82
7.68%
0.84
2.61%
0.79
5.10%
0.81
2.19%
1.30
59.59%
0.75
42.47%
0.47
37.16%
0.74
59.11%
intangibles to total assets
0.40
-
0.19
52.36%
0.04
78.54%
0.05
24.87%
0.04
25.72%
0.04
19.47%
0.01
72.96%
0.01
46.67%
0.05
653.36%
0.13
167.94%
0.19
42.88%
interest coverage
-31.48
-
-12.26
-
-7.40
39.64%
-7.43
0.40%
-8.31
11.85%
-5.68
31.66%
-12.68
123.26%
-35.19
177.58%
353.14
1,103.50%
89.78
74.58%
interest debt per share
0.48
-
81.02
-
76.29
5.83%
63.48
16.79%
35.38
44.27%
14.08
60.19%
112.38
698.00%
83.72
25.50%
1.39
98.34%
0.86
37.85%
inventory turnover
54.15
-
0.06
99.90%
invested capital
2.56
-
2.83
10.73%
1.55
45.26%
10.10
551.20%
0.58
94.25%
0.30
48.15%
0.44
45.28%
1.11
153.56%
23.57M
2,123,467,933.27%
market cap
26.48M
-
67.92M
156.45%
58.30M
14.16%
34.40M
41.00%
9.57M
72.18%
13.16M
37.54%
139.40M
959.37%
11.82M
91.52%
2.30M
80.51%
149.39M
6,388.56%
7.70M
94.85%
net current asset value
3.52M
-
8.86M
151.79%
-3.65M
141.21%
-18.52M
407.48%
-10.63M
42.59%
-23.32M
119.31%
24.17M
203.62%
66.20M
173.93%
9.15M
86.18%
433K
95.27%
8.26M
1,808.08%
net debt to ebitda
1.09
-
1.51
38.63%
-0.27
118.04%
-1.37
404.36%
-0.73
46.54%
-1.47
100.23%
1.89
228.95%
1.44
23.71%
-0.11
107.76%
-0.44
289.26%
0.70
259.50%
net income per share
-14.56
-
-23.17
59.16%
-30.15
30.13%
-40.77
35.24%
-37.87
7.11%
-23.24
38.64%
-7.53
67.60%
-74.31
886.79%
-146.21
96.76%
-2.39
98.36%
-6.50
171.60%
operating cash flow per share
-16.34
-
-16.52
1.10%
-24.92
50.84%
-36.93
48.18%
-31.70
14.16%
-18.46
41.77%
-5.31
71.22%
-96.05
1,707.88%
-107.44
11.86%
-2.49
97.69%
-4.84
94.85%
payables turnover
0.65
-
0.05
92.19%
receivables turnover
1
-
4.16
315.96%
1.56
62.39%
2.25
43.92%
5.92
162.94%
20.80
251.42%
0.29
98.60%
0.43
47.32%
0.39
8.95%
0.32
-
research and ddevelopement to revenue
-0.73
-
1.89
358.05%
3.33
76.31%
10.45
213.87%
8.98
14.08%
2.71
69.78%
1.96
27.69%
4.21
114.78%
7.44
76.59%
23.04
-
return on tangible assets
-0.94
-
-0.65
30.11%
-0.20
69.83%
-0.43
115.53%
-0.39
8.62%
-0.60
55.05%
-0.20
66.25%
-0.16
21.64%
-0.54
238.64%
-0.82
51.70%
-1.07
30.26%
revenue per share
0.81
-
6.47
695.24%
2.93
54.78%
1.11
62.23%
1.04
5.54%
2.67
155.30%
0.65
75.54%
7.58
1,061.60%
6.83
9.82%
0.06
-
roe
-0.60
-
-0.59
1.86%
-0.98
66.57%
-1.63
65.91%
-1.00
38.89%
-7.14
617.00%
-0.33
95.32%
-0.21
35.88%
-0.80
275.08%
-1.91
137.19%
-1.17
38.71%
roic
-0.64
-
-0.59
7.00%
-0.16
72.72%
-0.25
51.69%
-0.21
12.37%
-0.30
40.59%
-0.13
56.25%
-0.18
35.96%
-0.52
189.24%
-0.80
54.08%
-0.62
22.26%
sales general and administrative to revenue
20.46
-
2.71
86.74%
8.11
198.79%
26.78
230.34%
24.07
10.13%
6.11
74.61%
7.59
24.16%
9.29
22.47%
14.32
54.13%
51.88
-
shareholders equity per share
24.21
-
39.27
62.18%
30.68
21.88%
25.01
18.49%
38.02
52.01%
3.25
91.44%
22.54
592.83%
346.92
1,439.06%
181.99
47.54%
1.26
99.31%
5.57
343.13%
stock based compensation to revenue
5.24
-
0.49
90.58%
1.31
165.96%
2.56
95.19%
1.73
32.35%
0.12
93.11%
0.24
98.35%
0.67
182.39%
1.84
174.59%
9.06
-
tangible asset value
3.52M
-
8.87M
151.73%
21.95M
147.46%
7.09M
67.69%
14.54M
105.08%
1.08M
92.55%
55.46M
5,021.24%
107.62M
94.03%
58.63M
45.52%
9.99M
82.96%
15.96M
59.67%
tangible book value per share
13.99
-
31.02
121.71%
67.78
118.49%
19.90
70.64%
34.20
71.90%
1.43
95.82%
22.08
1,443.51%
343.82
1,457.09%
168.08
51.11%
0.82
99.51%
4.16
410.36%
working capital
3.52M
-
8.86M
151.79%
21.61M
144.02%
6.56M
69.66%
14.25M
117.26%
1.35M
90.53%
56.51M
4,086.07%
97.95M
73.33%
14.63M
85.06%
4.68M
68.04%
11.83M
152.98%

All numbers in (except ratios and percentages)